SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

BACKGROUND: In this study, we investigated the prediction and prognostic value of SDF-1 for triple-negative breast cancer (TNBC) patients who underwent neoadjuvant chemotherapy (NAC) following standard radical surgery. METHODS: A total of 303 TNBC patients were included in this study. The NAC regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruo-Xi, Ji, Peng, Gong, Yue, Shao, Zhi-Ming, Chen, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630559/
https://www.ncbi.nlm.nih.gov/pubmed/36341391
http://dx.doi.org/10.3389/fimmu.2022.940635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630559/
https://www.ncbi.nlm.nih.gov/pubmed/36341391
http://dx.doi.org/10.3389/fimmu.2022.940635

Ejemplares similares